Back to Agenda
Novel Approaches to Pharmacovigilance Collaboration
Session Chair(s)
Jose Vega, MD
Chief Safety Officer , Moderna, United States
Following the success of its clinical initiatives, TransCelerate launched its first pharmacovigilance projects in 2017, which are now actively engaging with health authorities and delivering both near-term and long-term value. This session will feature a panel of leaders from TransCelerate’s pharmacovigilance teams, as they discuss the future of pharmacovigilance (challenges associated with globalization, data automation, new PV requirements, etc.) and discuss initiatives that TransCelerate has undertaken to address these challenges.
Learning Objective : Describe expert perspectives on the future of the field of clinical safety and pharmacovigilance, with a focus on trends, challenges, and how collaborations can work to advance the industry in this space; Discuss strategies to address pharmacovigilance challenges.
Speaker(s)
Jose Vega, MD
Chief Safety Officer , Moderna, United States
Peter Verdru, MD
Vice President, Head of Patient Safety, UCB Biopharma S.P.R.L., Belgium
Ajay B. Singh
Team Leader, Safety Evaluation and Risk Management, GlaxoSmithKline, United States
Jeremy Jokinen, MS
Vice President Global Patient Safety, Argenx, United States
Gerald Dal Pan, MD, MHS
Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Have an account?